Skip to main content
PMVP logo

PMV Pharmaceuticals, Inc.

PMVPNASDAQHealthcareBiotechnology

$1.13Today:- (-)1Y −17.41%

As of Oct 26, 2026 close

Market cap
$60.33M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.02$1.91
Volume (live)
-
Avg. volume (3M)
747.17K

PMV Pharmaceuticals, Inc. (PMVP) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for PMV Pharmaceuticals, Inc. stock.

Analyst Consensus Rating

Investment consensus from 6 professional research analysts

Consensus Rating

Buy
Based on 6 unique analysts
Medium Confidence∞:1 Buy/Sell

Average Price Target

$4.20
+271.68% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest PMVP Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Robert Burns
HC Wainwright
BuyReiterates
$5.00
Unknown Analyst
Craig-Hallum
BuyReiterates
$4.00
Jeff Jones
Oppenheimer
BuyReiterates
$5.00
Jonathan Miller
Evercore ISI Group
BuyMaintains
$4.00
Rick Bienkowski
Ladenburg Thalmann
BuyReiterates
$3.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 12, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for PMVP?

The analyst consensus rating for PMVP is Buy, based on the latest ratings from 6 analysts over the last 90 days.

What is the average price target for PMVP?

The average 12-month price target for PMVP is $4.20, representing an upside of 271.7% from the Oct 26, 2026 close of $1.13.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.